K

Kiniksa Pharmaceuticals

Biopharmaceutical therapies for debilitating diseases

Senior Scientist Clinical Bioanalysis

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeLexington, MA, USA$161k - $186k

About the Job

Requirements

  • A Master of Science or PhD in Analytical Biochemistry, Cell Biology, Immunology, or a related life science discipline is required; a PhD in a related field is preferred.
  • Candidates with an MS must have 4 or more years of direct industry experience; candidates with a PhD must have 2 or more years of direct industry experience in biotech, biopharmaceutical, or CRO settings supporting translational and clinical bioanalysis.
  • Experience working with clinical central laboratories, including coordinating sample logistics, assay execution, and data delivery for clinical studies.
  • Hands-on experience with bioanalytical platforms used in immune disease research, including ligand-binding assays such as ELISA and MSD/ECL, multiplex cytokine and protein panels, flow cytometry and immune cell phenotyping assays, and cell-based functional assays.
  • Experience collaborating across multidisciplinary teams and managing external partners.
  • Strong attention to bioanalytical details for regulatory compliance.
  • Strong written and verbal communication skills to convey complex scientific and operational information clearly.

Responsibilities

  • Collaborate with internal Research development to perform late-stage development, qualification/validation, and implementation of translational and clinical biomarker assays supporting immune-mediated disease programs.
  • Participate as a bioanalytical subject matter expert on cross-functional project teams, working closely with internal early Research, Clinical Development and Operations, Clinical Pharmacology, Regulatory, and Biostatistics.
  • Contribute as a subject matter expert to bioanalytical assay development strategy and execution for measuring target engagement and pharmacodynamic responses, including cytokines, chemokines, soluble receptors, and immune cell markers, and other measures associated with the immune biology of clinical studies.
  • Support DMPK bioanalysis activities, including PK, ADA, and PD biomarker integration, for biologics and novel therapeutic modalities.
  • Partner with Clinical Development and Operations to provide subject matter expert support to central lab activities aligned with current regulatory guidance and industry best practices while remaining fit-for-purpose for each development phase.
  • Develop sample collection and handling strategies.
  • Conduct assay feasibility assessments and support operational readiness.
  • Support method transfer, validation, and clinical sample testing.
  • Review data, resolve queries, and manage issues.
  • Collaborate with external CRO partners to ensure high-quality, on-time delivery of bioanalytical data.
  • Manage multiple bioanalytical projects simultaneously while maintaining scientific rigor, operational excellence, and assigned timelines.

Desired Qualifications

  • Strong background in immunology-focused biomarker assay development and clinical implementation.
  • Working knowledge of DMPK bioanalysis, including PK and ADA assessments.
  • Familiarity with regulatory expectations and industry best practices for bioanalytical assays and clinical laboratory operations.
  • A PhD in a related field is preferred.

About the Company

Kiniksa Pharmaceuticals

Biopharmaceutical therapies for debilitating diseases

Kiniksa Pharmaceuticals develops and delivers therapies for patients with serious diseases that have few good treatment options. The company focuses on research and development, conducts clinical trials, and then brings approved therapies to market. Its products are created through an R&D process and are intended to be used by patients via the healthcare system, with outcomes measured to help save or improve lives. What sets Kiniksa apart is its patient-centric approach and commitment to urgency and integrity, along with a business model that combines internal R&D with partnerships and licensing to bring therapies to patients. The company aims to improve patient outcomes and quality of life by delivering effective treatments where options are limited.

Company size
201-500
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Kiniksa Pharmaceuticals

See more jobs